What are Oligonucleotides? How is ‘oligonucleotides’ pronounced? How are oligonucleotides synthesised? What are the uses and benefits of oligonucleotides in the pharmaceutical industry? We will be answering all of these questions and more in our first episode of ‘Big Concepts in Brief’.
Helping us demystify this Big Concept is Claire MacLeod, a Grand Challenge Lead at CPI’s Medicines Manufacturing Innovation Centre in Glasgow City Region, Scotland.
These synthesised short strands of RNA or DNA have the potential to revolutionise medicine and the pharmaceutical industry. They operate at the most basic level within our cells – our genes. Once delivered into our bodies, they target highly specific genetic sequences to modify the production of proteins that cause various diseases.
This next-generation drug modality has the potential to treat a wide range of diseases like Alzheimer’s, spinal muscular atrophy, cardiovascular diseases, and cancer. At CPI, we’re leading the research and development effort with our partners to make oligonucleotide medicines a viable, cost-effective and sustainable therapy for large patient populations.
Let us know what you think of this innovation and any other concepts you would like explained in this series in the comment section below.
---------------------------------------------------
About this series:
Welcome to 'Big Concepts in Brief'! In the fast-paced world of science and technology innovation, we often come across big and complex words that can be overwhelming. But fear not! In this series, we break those big concepts down into smaller, more digestible bites.
At CPI, our incredible experts and innovation enablers collaborate with partners from various sectors and industries. So, who better to explain these concepts in simpler terms? From defining a concept and helping you pronounce it correctly, to understanding an underlying mechanism and exploring its benefits and uses – we've got you covered!
Our knowledgeable and passionate experts will demystify complex ideas and make them accessible to everyone. Whether you're a science enthusiast, a tech-savvy individual, or just someone curious about the world of innovation, this series is for you.
---------------------------------------------------
Explore more incredible stories from our people on our social channels:
LinkedIn – [ Ссылка ]
Instagram – [ Ссылка ]
Facebook – [ Ссылка ]
Twitter – [ Ссылка ]
---------------------------------------------------
About CPI:
CPI connects the dots within the innovation ecosystem to make great ideas and inventions a reality to benefit people, places and our planet. We’re a pioneering social enterprise that accelerates the development, scale-up and commercialisation of deep tech and sustainable manufacturing solutions. Through our incredible innovation experts and infrastructure, we look beyond the obvious to transform healthcare and drive towards a sustainable future.
As a trusted partner of industry, academia, government, and the investment community, we’re the catalyst for delivering smart AgriFoodTech, energy storage, HealthTech, materials, and pharma innovations. We believe by working together we can build a better collective future, and as part of the High Value Manufacturing Catapult, we facilitate access to world-class organisations to deliver transformation across industries.
Creating lasting global impact from the North of England and Scotland, we invest in people and disruptive technologies to invigorate economies, create circular supply chains and make our world a better place.
Let's innovate together: [ Ссылка ]
---------------------------------------------------
